TechNavio today published its report Global Inhalation Systems Market 2010“2014 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision-makers™ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio™s Healthcare team said, The emergence of sophisticated inhaler devices is particularly attractive to the younger population suffering from chronic respiratory diseases. The new field of therapeutic aerosol bioengineering (TAB), driven primarily by the medical need for inhaled insulin, is now expanding to address medical needs ranging from respiratory to systemic diseases, including asthma, growth deficiency, and pain. Besides, vendors are creating new inhalers in different sizes, shapes, colors, and materials. This trend is expected to have a strong impact on the market.
According to the report, the prevalence of asthma and COPD is increasing in developed and developing countries at a rate of 15 percent and 11 percent, respectively. It is estimated that about 300 million people were suffering from asthma worldwide in 2010. Due to chronic lifestyle-induced disorders, mortality arising out of asthma, too, is on the rise.
The report also discusses that the reduction in the insurance reimbursement amount could pose a challenge to the growth of this market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/global-inhalation-systems-market-2010-2014
Follow us on Twitter @Technavio
TechNavio Announces the Publication of its Report – Global Inhalation Systems Market 2010-2014
